Literature DB >> 33640109

Impact of a C. difficile infection (CDI) reduction bundle and its components on CDI diagnosis and prevention.

Natalia Blanco1, Gwen L Robinson2, Emily L Heil3, Rebecca Perlmutter4, Lucy E Wilson4, Clayton H Brown5, Mojdeh S Heavner6, Gita Nadimpalli2, Daniel Lemkin7, Daniel J Morgan8, Surbhi Leekha2.   

Abstract

BACKGROUND: Published bundles to reduce Clostridioides difficile Infection (CDI) frequently lack information on compliance with individual elements. We piloted a computerized clinical decision support-based intervention bundle and conducted detailed evaluation of several intervention-related measures.
METHODS: A quasi-experimental study of a bundled intervention was performed at 2 acute care community hospitals in Maryland. The bundle had five components: (1) timely placement in enteric precautions, (2) appropriate CDI testing, (3) reducing proton-pump inhibitor (PPI) use, (4) reducing high-CDI risk antibiotic use, and (5) optimizing use of a sporicidal agent for environmental cleaning. Chi-square and Kruskal-Wallis tests were used to compare measure differences. An interrupted time series analysis was used to evaluate impact on hospital-onset (HO)-CDI.
RESULTS: Placement of CDI suspects in enteric precautions before test results did not change. Only hospital B decreased the frequency of CDI testing and reduced inappropriate testing related to laxative use. Both hospitals reduced the use of PPI and high-risk antibiotics. A 75% decrease in HO-CDI immediately postimplementation was observed for hospital B only.
CONCLUSION: A CDI reduction bundle showed variable impact on relevant measures. Hospital-specific differential uptake of bundle elements may explain differences in effectiveness, and emphasizes the importance of measuring processes and intermediate outcomes.
Copyright © 2020 Association for Professionals in Infection Control and Epidemiology, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Antibiotic resistance; Computerized clinical decision support; Hospital infection control

Mesh:

Year:  2021        PMID: 33640109     DOI: 10.1016/j.ajic.2020.10.020

Source DB:  PubMed          Journal:  Am J Infect Control        ISSN: 0196-6553            Impact factor:   2.918


  2 in total

1.  Nitro-Group-Containing Thiopeptide Derivatives as Promising Agents to Target Clostridioides difficile.

Authors:  Dahyun Kim; Young-Rok Kim; Hee-Jong Hwang; Marco A Ciufolini; Jusuk Lee; Hakyeong Lee; Shyaka Clovis; Sungji Jung; Sang-Hun Oh; Young-Jin Son; Jin-Hwan Kwak
Journal:  Pharmaceuticals (Basel)       Date:  2022-05-19

2.  Impact of Statewide Prevention and Reduction of Clostridioides difficile (SPARC), a Maryland public health-academic collaborative: an evaluation of a quality improvement intervention.

Authors:  Clare Rock; Rebecca Perlmutter; David Blythe; Jacqueline Bork; Kimberly Claeys; Sara E Cosgrove; Kate Dzintars; Valeria Fabre; Anthony D Harris; Emily Heil; Yea-Jen Hsu; Sara Keller; Lisa L Maragakis; Aaron M Milstone; Daniel J Morgan; Prashila Dullabh; Petry S Ubri; Christina Rotondo; Richard Brooks; Surbhi Leekha
Journal:  BMJ Qual Saf       Date:  2021-12-09       Impact factor: 7.035

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.